MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/07/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization941,857 mln
Float889 mln
Earnings Date04/30/2026
EPS
24.72
Exceptional
P / E
43.75
High premium
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-1.67
Likely manipulated
Relative Strength
90
/ 100
Top performer
Debt / Equity
1.39
Elevated leverage
Business Description
Founded in 1876 and based in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical firm that researches, produces, and sells medicines across the United States, Europe, Asia, and beyond. The company's portfolio spans several major health areas, including diabetes and weight management, cancer treatment, immune system disorders, and neurological conditions such as migraines and Alzheimer's disease. Eli Lilly works alongside several partner companies, including Boehringer Ingelheim, Roche, and Genentech, to bring key products to market.
